Clinical Trials Insight: 700056404
Latest Information Update: 24 May 2010
At a glance
- Drugs Ipilimumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 24 May 2010 New trial record